Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|April 2, 2005
A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancerShanu Modi, Andrew D Seidman, Maura Dickler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2007
Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21Teresa A Gilewski, Govind Ragupathi, Maura Dickler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without BevacizumabMark Jesus M Magbanua, Oleksandr Savenkov, Erik J Asmus, et al.
The Journal of Sexual Medicine|January 29, 2013
A national network to advance the field of cancer and female sexualityShari B Goldfarb, Emily Abramsohn, Barbara L Andersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumabShanu Modi, Alison Stopeck, Hannah Linden, et al.
American Journal of Clinical Pathology|October 16, 2019
Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical TrialsHala Makhlouf, Mark A Watson, Heather A Lankes, et al.
Patient Education and Counseling|June 9, 2018
A rigorous evaluation of an institutionally-based communication skills program for post-graduate oncology traineesCarma L Bylund, Smita C Banerjee, Philip A Bialer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancerKathy D Miller, Linnea I Chap, Frankie A Holmes, et al.
Pageof 5